Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Sorafenib

Various toxicities in elderly patients: 7 case reports

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kokudo N, Nakajima J, Hatano E, Numata K.Current status of hepatocellular carcinoma treatment in Japan: Practical use of sorafenib (Nexavar). Clinical Drug Investigation 32 (Suppl. 2): 25-35, 8 Aug 2012. Available from: URL: http://dx.doi.org/10.2165/1163023-S0-000000000-00000 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Sorafenib. React. Wkly. 1422, 44 (2012). https://doi.org/10.2165/00128415-201214220-00147

    Download citation

    Keywords

    • Public Health
    • Carcinoma
    • Adverse Event
    • Hepatocellular Carcinoma
    • Patient Outcome